last
three
decad
mani
effort
made
studi
protein
cleavag
site
diseasecaus
enzym
hiv
human
immunodefici
viru
proteas
sar
sever
acut
respiratori
syndrom
coronaviru
main
proteinas
becom
increasingli
clear
via
minireview
motiv
drive
aforement
studi
quit
wise
result
acquir
studi
reward
particularli
develop
peptid
drug
journal
preproof
j
u
r
n
l
p
r
e
p
r
f
furthermor
webserv
call
hivcleav
establish
predict
hiv
proteas
cleavag
site
protein
websit
address
like
pseudo
amino
acid
compon
rule
stimul
develop
sequenc
bioinformat
wide
increasingli
use
proteom
genom
analysi
anticip
distort
key
theori
stimul
structur
bioinformat
well
pioneer
studi
followup
studi
also
wide
increasingli
use
drug
develop
particularli
develop
peptid
drug
multitarget
drug
journal
preproof
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
j
u
r
n
l
p
r
e
p
r
f
figur
journal
preproof
j
u
r
n
l
p
r
e
p
r
f
figur
schemat
illustr
show
peptid
good
fit
tightli
bind
enzym
activ
site
cleav
latter
adapt
permiss
human
immunodefici
viru
infect
acquir
immun
defici
syndrom
hivaid
caus
infect
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
sar
viral
respiratori
diseas
zoonot
origin
caus
sar
coronaviru
sarscov
last
two
decad
mani
effort
made
studi
protein
cleavag
site
hiv
proteas
see
eg
sar
coronaviru
main
proteinas
becom
clear
motiv
drive
aforement
studi
quit
wise
result
acquir
studi
reward
without
lose
gener
let
us
consid
case
hiv
proteas
function
dimmer
two
ident
subunit
hiv
proteas
crablik
shape
catalyt
cleft
gate
pair
flap
pincer
view
crab
enzym
inhibitorfre
state
pincerg
open
allow
substrat
enter
catalyt
cleft
inhibitorbind
state
pincerg
close
block
entranc
member
aspartyl
proteas
hiv
proteas
highli
substrateselect
cleavagespecif
suscept
site
protein
extend
octapeptid
region
accord
fisher
lock
key
model
koshland
induc
fit
theori
rack
mechan
prerequisit
condit
peptid
cleav
diseasecaus
enzym
good
fit
tightli
bind
enzym
activ
site
howev
peptid
modif
scissil
bond
simpl
chemic
procedur
longer
cleavabl
enzym
still
tightli
bind
activ
site
illustr
distort
key
theori
given
panel
show
effect
bind
cleavabl
peptid
activ
site
hiv
proteas
panel
b
peptid
becom
noncleav
one
scissil
bond
modifi
although
still
bind
activ
site
modifi
peptid
distort
key
automat
becom
inhibitor
candid
hiv
proteas
even
nonpeptid
inhibitor
inform
deriv
cleavabl
peptid
also
provid
use
insight
key
bind
group
fit
conform
sens
microenviron
besid
peptid
drug
usual
toxic
vivo
physiolog
concentr
discuss
distort
key
theori
see
comprehens
review
paper
base
distort
key
theori
mani
investig
enthusiast
develop
variou
method
predict
protein
cleavag
site
diseasecaus
enzym
see
eg
analyz
codon
usag
approach
function
dimmer
two
ident
subunit
hiv
proteas
crablik
shape
catalyt
cleft
gate
pair
flap
pincer
view
crab
enzym
inhibitorfre
state
pincerg
open
allow
substrat
enter
catalyt
cleft
inhibitorbind
state
pincerg
close
block
entranc
adapt
permiss
show
effect
bind
cleavabl
peptid
activ
site
diseasecaus
enzym
panel
b
peptid
becom
noncleav
one
scissil
bond
modifi
although
still
bind
activ
site
modifi
peptid
distort
key
automat
becom
inhibitor
candid
diseasecaus
enzym
adapt
permiss
author
claim
conflict
interest
whatsoev
paper
